Justine Berthet

4PUBLICATIONS
53CO-AUTHORS
Predictive and prognostic markersCellular immunologyGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 16, 2025
Unraveling the Tumor Microenvironment and PD-L1 Expression across Tissue Types in High-Grade Serous Ovarian Cancer in the NeoPembrOV/GINECO Phase II Randomized Trial.

Laetitia Collet, Maude Ardin, David Venet

|Jan 08, 2025
The Spatial Organization of cDC1 with CD8+ T Cells is Critical for the Response to Immune Checkpoint Inhibitors in Patients with Melanoma.

Elisa Gobbini, Margaux Hubert, Anne-Claire Doffin

|Jan 24, 2024
The CSF-1R inhibitor pexidartinib affects FLT3-dependent DC differentiation and may antagonize durvalumab effect in patients with advanced cancers.

Aurélien Voissière, Carlos Gomez-Roca, Sylvie Chabaud

|Apr 19, 2020
IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer.

Margaux Hubert, Elisa Gobbini, Coline Couillault

Pageof 1

Frequent Collaborators

4 joint publications

Christophe Caux

4 joint publications

Bertrand Dubois

2 joint publications

Margaux Hubert

2 joint publications

Elisa Gobbini